IMTX
Price
$9.78
Change
-$0.37 (-3.65%)
Updated
Apr 25, 6:59 PM EST
18 days until earnings call
MORF
Price
$27.98
Change
+$0.29 (+1.05%)
Updated
Apr 25, 6:59 PM EST
96 days until earnings call
Ad is loading...

IMTX vs MORF ᐉ Comparison: Which is Better to Invest?

Header iconIMTX vs MORF Comparison
Open Charts IMTX vs MORFBanner chart's image
Immatics
Price$9.78
Change-$0.37 (-3.65%)
Volume$547.92K
CapitalizationN/A
Morphic Holding
Price$27.98
Change+$0.29 (+1.05%)
Volume$547.16K
CapitalizationN/A
View a ticker or compare two or three
IMTX vs MORF Comparison Chart

Loading...

IMTXDaily Signal changed days agoGain/Loss if shorted
 
Show more...
MORFDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
IMTX vs. MORF commentary
Apr 26, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IMTX is a Hold and MORF is a StrongSell.

COMPARISON
Comparison
Apr 26, 2024
Stock price -- (IMTX: $9.78 vs. MORF: $27.98)
Brand notoriety: IMTX and MORF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IMTX: 156% vs. MORF: 183%
Market capitalization -- IMTX: $1.01B vs. MORF: $1.4B
IMTX [@Biotechnology] is valued at $1.01B. MORF’s [@Biotechnology] market capitalization is $1.4B. The market cap for tickers in the [@Biotechnology] industry ranges from $562.44B to $0. The average market capitalization across the [@Biotechnology] industry is $2.55B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IMTX’s FA Score shows that 0 FA rating(s) are green whileMORF’s FA Score has 0 green FA rating(s).

  • IMTX’s FA Score: 0 green, 5 red.
  • MORF’s FA Score: 0 green, 5 red.
According to our system of comparison, both IMTX and MORF are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IMTX’s TA Score shows that 3 TA indicator(s) are bullish while MORF’s TA Score has 5 bullish TA indicator(s).

  • IMTX’s TA Score: 3 bullish, 5 bearish.
  • MORF’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, MORF is a better buy in the short-term than IMTX.

Price Growth

IMTX (@Biotechnology) experienced а -4.68% price change this week, while MORF (@Biotechnology) price change was +1.71% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +8.00%. For the same industry, the average monthly price growth was -2.94%, and the average quarterly price growth was +1264.32%.

Reported Earning Dates

IMTX is expected to report earnings on Aug 06, 2024.

MORF is expected to report earnings on Jul 31, 2024.

Industries' Descriptions

@Biotechnology (+8.00% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for IMTX with price predictions.
OPEN
A.I.dvisor published
a Summary for MORF with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
MORF($1.4B) has a higher market cap than IMTX($1.01B). MORF YTD gains are higher at: -3.116 vs. IMTX (-7.123).
IMTXMORFIMTX / MORF
Capitalization1.01B1.4B72%
EBITDAN/AN/A-
Gain YTD-7.123-3.116229%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
TECHNICAL ANALYSIS
Technical Analysis
IMTXMORF
RSI
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 1 day ago
83%
Momentum
ODDS (%)
Bearish Trend 1 day ago
58%
Bearish Trend 1 day ago
79%
MACD
ODDS (%)
N/A
Bullish Trend 1 day ago
82%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
70%
Bullish Trend 1 day ago
81%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
66%
Bearish Trend 1 day ago
82%
Advances
ODDS (%)
N/A
Bullish Trend 4 days ago
83%
Declines
ODDS (%)
Bearish Trend 1 day ago
74%
N/A
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
74%
Bearish Trend 1 day ago
85%
View a ticker or compare two or three
Ad is loading...
IMTXDaily Signal changed days agoGain/Loss if shorted
 
Show more...
MORFDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GTSDX8.27N/A
N/A
Invesco Small Cap Growth C
SMFCX25.53-0.03
-0.12%
American Beacon Stephens Mid-Cap Gr C
PIXEX24.98-0.05
-0.20%
Principal Glb Emerging Markets R1
TIBIX24.79-0.06
-0.24%
Thornburg Investment Income Builder I
JLGAX18.29-0.13
-0.71%
JAG Large Cap Growth A

IMTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMTX has been loosely correlated with IMCR. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if IMTX jumps, then IMCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMTX
1D Price
Change %
IMTX100%
-3.65%
IMCR - IMTX
38%
Loosely correlated
-0.80%
KNSA - IMTX
36%
Loosely correlated
-1.40%
SCPH - IMTX
35%
Loosely correlated
-3.33%
INBX - IMTX
34%
Loosely correlated
-0.84%
PRME - IMTX
33%
Loosely correlated
-8.51%
More

MORF and

Correlation & Price change

A.I.dvisor indicates that over the last year, MORF has been loosely correlated with ORMP. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if MORF jumps, then ORMP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MORF
1D Price
Change %
MORF100%
+1.05%
ORMP - MORF
45%
Loosely correlated
-2.95%
AXON - MORF
43%
Loosely correlated
+1.27%
ARRY - MORF
42%
Loosely correlated
-2.37%
SRPT - MORF
42%
Loosely correlated
+2.53%
EDIT - MORF
41%
Loosely correlated
-2.43%
More